| Literature DB >> 25790294 |
Hsien-Fu Chiu1, Mei-Chin Wen2, Jian-Ri Li3, Hao-Chung Ho3, Kuo-Hsiung Shu1,4.
Abstract
Angiomyolipoma (AML) is a benign mesenchymal tumor composed of blood vessels, smooth muscle, and mature adipose tissue. AMLs in the kidney allografts are rare. We report a case of AML that was incidentally found 1 year after transplantation. Abdominal computed tomography showed a 4-cm renal tumor with contrast enhancement and an early washout pattern, resembling a renal cell carcinoma. Tumor biopsy proved a lipid-poor AML. Tumor diameter decreased to 2.4 cm after 6 months of treatment with sirolimus. Sirolimus not only reduces tumor size, but also benefits a transplant patient who needs immunosuppression.Entities:
Keywords: angiomyolipoma; mammalian target of rapamycin inhibitor; renal cell carcinoma; renal transplantation
Mesh:
Substances:
Year: 2015 PMID: 25790294 DOI: 10.1111/tri.12567
Source DB: PubMed Journal: Transpl Int ISSN: 0934-0874 Impact factor: 3.782